KLK2 and neoplasm: For example, cancer RNA biomarkers such as KRAS, PCA3, PIK3CA mutants, EGFRvIII, FOLH1, KLK2, KLK3, EML4-ALK, and NYP have been reported to be sequestered by platelets that actively uptake tumor-derived material [189].